Vaxigrip suspension for injection in pre-filled syringe
*Company:
SANOFIStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company

Updated on 17 August 2026
File name
1.3.1.1 Summary of Product Characteristics (SmPC) Vaxigrip TIV (1).pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 17 August 2026
File name
1.3.1.3 Package Leaflet (PIL text) Vaxigrip TIV.pdf
Reasons for updating
- Change to section 6 - what the product contains
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - marketing authorisation number
- Change to section 6 - manufacturer
Updated on 08 July 2025
File name
314 Vaxigrip TIV - IE - PIL text - ASV NH2025-26.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 08 July 2025
File name
314 Vaxigrip TIV - IE - SmPC - ASV NH2025-26 - 25Jun25 (1).pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 10 April 2025
File name
314 Vaxigrip TIV - IE - SmPC - Immunity Persistence - clean.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.4 - Special precautions for storage
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 26 March 2025
File name
314 - Vaxigrip TIV - IE - PIL text - clean - DEHxxxxIA1132G.pdf
Reasons for updating
- New PIL for new product
Updated on 26 March 2025
File name
314 Vaxigrip TIV - IE SmPC clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
SANOFI

Address:
Citywest Business Campus, Dublin 24, IrelandMedical Information E-mail:
iemedinfo@sanofi.comTelephone:
+353 1 4035600
